Brian Ellacott, President and CEO of LABORIE along with the EAU Secretary-General, Professor Christopher Chapple presented the prestigious Matula Award to Dr. Christian Gratzke at the opening ceremony of the 32nd Annual EAU meeting in London, UK.
The Crystal Matula Award is the most prestigious prize given to a young promising European urologist under the age of 40 who has the potential to become one of the future leaders in academic European urology. The award includes an honorarium of 10,000 Euro supported by an educational grant from LABORIE Medical Technologies.
EAU recognized LABORIE for celebrating its 50th Anniversary, valuing their 50 years of contributions to functional urology and the advancement of urodynamics.
|2007||M. S. Michel|
|2006||A. De La Taille|
The European Association of Urology (EAU) represents the leading authority within Europe on urological practice, research and education. Over 15,000 medical professionals have joined its ranks and contribute to our mission: To raise the level of urological care throughout Europe and beyond.
LABORIE is an industry-leading manufacturer and supplier of pelvic health and gastrointestinal equipment and consumables. Since it’s founding in 1967, LABORIE has been committed to delivering innovative, complete solutions that provide better diagnostics and treatment outcomes to patients worldwide. LABORIE is a subsidiary of Patricia Industries.
LABORIE Medical Technologies (“LABORIE”) and Cogentix Medical, Inc. (NASDAQ: CGNT) (“Cogentix”) today announced the completion of the acquisition by LABORIE of Cogentix through LABORIE’S affiliate Camden Merger Sub, Inc. (“Merger Sub”), a wholly owned subsidiary of LM US Parent, Inc. (“Parent”).
LABORIE Medical Technologies (“LABORIE”) announced the successful completion of the tender offer by its affiliate Camden Merger Sub, Inc. (“Merger Sub”), a wholly owned subsidiary of LM US Parent, Inc. (“Parent”) to purchase all outstanding shares of common stock of Cogentix Medical, Inc. (NASDAQ: CGNT) (“Cogentix”)
LABORIE Medical Technologies, a leading global developer and manufacturer of medical diagnostics and devices in the pelvic health and gastroenterology market, today announces the execution of a definitive agreement to acquire Cogentix Medical Inc., (NASDAQ: CGNT)